John Overdeck’s Milestone Pharmaceuticals MIST Stock Holding History

John Overdeck’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.73M	Sell	2,040,015 -277,161	-12%	-$443K	﹤0.01%	2713
2026 Q1	$2.76M	Buy	2,317,176 +802,715	+53%	+$1.41M	﹤0.01%	2502
2025 Q4	$3.06M	Buy	1,514,461 +847,910	+127%	+$1.83M	﹤0.01%	2130
2025 Q3	$1.33M	Buy	+666,551	New	+$1.17M	﹤0.01%	2396
2023 Q3	–	Sell	-52,186	Closed	-$149K	–	3110
2023 Q2	$149K	Buy	52,186 +16,879	+48%	+$63.7K	﹤0.01%	2697
2023 Q1	$139K	Sell	35,307 -159,036	-82%	-$581K	﹤0.01%	2626
2022 Q4	$770K	Buy	+194,343	New	+$1.02M	﹤0.01%	1836
2021 Q3	–	Sell	-16,235	Closed	-$89K	–	4517
2021 Q2	$89K	Sell	16,235 -38,578	-70%	-$219K	﹤0.01%	3915
2021 Q1	$317K	Sell	54,813 -2,598	-5%	-$19K	﹤0.01%	3288
2020 Q4	$385K	Buy	57,411 +37,509	+188%	+$251K	﹤0.01%	2679
2020 Q3	$146K	Buy	+19,902	New	+$143K	﹤0.01%	2889

Other funds holding MIST

PCM

Pavaki Capital Management Pueblo, Colorado $287M AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

John Overdeck's MIST Position: Q2 2026 in Review

John Overdeck reduced its Milestone Pharmaceuticals (MIST) stake by 12% in Q2 2026, selling an estimated $443K and leaving 2,040,015 shares worth $2.73M. The position accounts for ﹤0.01% of the portfolio, ranked #2713.

John Overdeck first reported a position in MIST in Q3 2020 and has held it in 11 quarters since. The position peaked at $3.06M in Q4 2025. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

John Overdeck held 2,040,015 shares of Milestone Pharmaceuticals worth $2.73M as of Q2 2026.
John Overdeck sold 277,161 Milestone Pharmaceuticals shares in Q2 2026, an estimated $443K.
Milestone Pharmaceuticals made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2713 holding.
John Overdeck first reported a position in Milestone Pharmaceuticals in Q3 2020 and has held it in 11 quarters since.
John Overdeck's Milestone Pharmaceuticals position peaked at $3.06M in Q4 2025.
78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.